Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT07315113 |
| Title | Study of NXP900 With Osimertinib in Subjects With Advanced, EGFR-Mutated Non-Small Cell Lung Cancer |
| Recruitment | Recruiting |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | Yes |
| Sponsors | Nuvectis Pharma, Inc. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Maryland Oncology Hematology | RECRUITING | Calverton | Maryland | 20705 | United States | Details |
| Massachusetts General Hospital | NOT_YET_RECRUITING | Boston | Massachusetts | 02114 | United States | Details |
| Willamette Valley Cancer Institute and Research Center | RECRUITING | Eugene | Oregon | 97401 | United States | Details |
| UPMC Hillman Cancer Center | RECRUITING | Pittsburgh | Pennsylvania | 15232 | United States | Details |
| NEXT Houston | RECRUITING | Houston | Texas | 77054 | United States | Details |
| NEXT Virginia | RECRUITING | Fairfax | Virginia | 22031 | United States | Details |